---
title: "Ocrelizumab - Primary Progressive Multiple Sclerosis"
sidebar: mydoc_sidebar
permalink: db11988-mesh-d020528-1.html
toc: false 
---


Path ID: `DB11988_MESH_D020528_1`
{% include image.html url="images/db11988-mesh-d020528-1.png" file="db11988-mesh-d020528-1.png" alt="db11988-mesh-d020528-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C533411">MESH:C533411 </a> | Ocrelizumab | Drug |
| <a href="https://identifiers.org/UniProt:P11836">UniProt:P11836 </a> | B-lymphocyte antigen CD20 | Protein |
| <a href="https://identifiers.org/CL:0000236">CL:0000236 </a> | B cell | Cell |
| <a href="https://identifiers.org/MESH:D020528">MESH:D020528 </a> | Primary progressive multiple sclerosis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ocrelizumab | NEGATIVELY REGULATES | B-Lymphocyte Antigen Cd20 |
| B-Lymphocyte Antigen Cd20 | EXPRESSED IN | B Cell |
| B Cell | CONTRIBUTES TO | Primary Progressive Multiple Sclerosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB11988](https://go.drugbank.com/drugs/DB11988)
